Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3018404 | 0.92 | KMT2A (0.64) | KMT2ASMN1; SMN2ESR1L3MBTL1ALDH1A1 | |
| SCHEMBL2439155 | 0.90 | KMT2A (0.57) | KMT2ASMN1; SMN2ESR1L3MBTL1ALDH1A1 | |
| SCHEMBL8123048 | 0.85 | SMN1; SMN2 (0.60) | SMN1; SMN2L3MBTL1ALDH1A1HPGDMAPT | |
| SCHEMBL3017737 | 0.83 | ESR1 (0.54) | KMT2AESR1L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL1245355 | 0.82 | KMT2A (0.55) | KMT2ASMN1; SMN2ALDH1A1MAPTCYP1A2 | |
| SCHEMBL3014662 | 0.81 | PPARG (0.48) | KMT2AESR1L3MBTL1ALDH1A1TDP1 | |
| SCHEMBL12966511 | 0.81 | THRA (0.58) | SMN1; SMN2ESR1L3MBTL1CREBBPHDAC1 | |
| SCHEMBL3017821 | 0.80 | NPC1 (0.56) | KMT2ASMN1; SMN2L3MBTL1ALDH1A1MAPT | |
| SCHEMBL2010422 | 0.80 | KMT2A (0.66) | KMT2ASMN1; SMN2ESR1ALDH1A1HPGD | |
| SCHEMBL3014488 | 0.79 | PTGDR2 (0.53) | KMT2AMAPTCREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197950-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HIGH POINT PHARMACEUTICALS, LLC | 2010-08-05 | — | — | US | disclosed |
| EP-2029507-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | High Point Pharmaceuticals, LLC (US) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007141295-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HIGH POINT PHARMACEUTICALS, LLC (US) | 2007-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197950-A1 | PROCESS FOR PREPARING PHENOXY ACETIC ACID DERIVATIVES | HAAO, HPD, PAH | KMT2A 395/4885SMN1; SMN2 3356/4885ESR1 3968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.